Erratum: Post-mastectomy breast reconstruction (BMJ (2013) 347 (f5903) DOI: 10.1136/bmj.f5903);Post-mastectomy breast reconstruction

BMJ (Online)

Volumn 347, Issue 7929, 2013, Pages

  Thiruchelvam, Paul T R ^a   McNeill, Fiona ^b   Jallali, Navid ^a   Harris, Paul ^b   Hogben, Katy ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACELLULAR DERMAL MATRIX; BACKACHE; BODY IMAGE; BREAST CALCIFICATION; BREAST CANCER; BREAST IMPLANT; BREAST NECROSIS; BREAST RECONSTRUCTION; BREAST TISSUE EXPANDER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; ESTHETICS; FAT NECROSIS; GRACILIS FLAP; HUMAN; INFORMED CONSENT; LATISSIMUS DORSI FLAP; LIPOMODELLING; MASTECTOMY; MASTITIS; NIPPLE MALFORMATION; PARTIAL MASTECTOMY; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SELF ESTEEM; SEROMA; SHOULDER PAIN; SUPERFICIAL INFERIOR EPIGASTRIC ARTERY FLAP; SURGICAL TECHNIQUE; THERAPY DELAY; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; TREATMENT INDICATION; WELLBEING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; FEMALE; METHODOLOGY; PSYCHOLOGICAL ASPECT; SURGICAL FLAPS; TIME; BREAST NEOPLASMS;

ACELLULAR DERMIS; BREAST IMPLANTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; RADIOTHERAPY, ADJUVANT; SURGICAL FLAPS; TIME FACTORS;

EID: 84886918326     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f6810     Document Type: Erratum

References (76)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, et al. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 2009;101:541-7.
3. Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012;107:1195-202.
4. Jeevan R, Cromwell D, Browne J, van der Meulen J, Caddy CM, Pereira J, et al. Second annual report of the national mastectomy and breast reconstruction audit 2009. NHS Information Centre, 2009. www.rcseng.ac.uk/surgeons/research/ surgical-research/docs/national-mastectomy-and-breast-reconstruction-audit- second-report-2009.
5. Lee C, Sunu C, Pignone M. Patient-reported outcomes of breast reconstruction after mastectomy: a systematic review. J Am Coll Surg 2009;209:123-33.
6. National Institute for Health and Care Excellence. Early and locally advanced breast cancer diagnosis and treatment, 2009. www.nice.org.uk/nicemedia/ pdf/cg80niceguideline.pdf.
7. Jeevan R, Browne J, van der Meulen J, Caddy CM, Pereira J, Sheppard C. First Annual Report of the National Mastectomy and Breast Reconstruction Audit 2008. NHS Information Centre, 2008. www.rcseng.ac.uk/surgeons/research/surgical- research/docs/nationalmastectomyand-breast-reconstruction-audit-first-report.
8. Bates T, Kearins O, Monypenny I, Lagord C, Lawrence G. Clinical outcome data for symptomatic breast cancer: the breast cancer clinical outcome measures (BCCOM) project. Br J Cancer 2009;101:395-402.
9. Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 2013;20:1436-43.
10. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 2007;25:5203-9. (Pubitemid 350232251)
11. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1or BRCA2mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol 2008;26:1093-7.
12. National Institute for Health and Care Excellence. Familial breast cancer. Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. 2013. www.nice.org.uk/nicemedia/live/14188/64202/64202.pdf.
13. Neuburger J, Macneill F, Jeevan R, van der Meulen JH, Cromwell DA. Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ Open 2013;3:e003179.
14. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-Refaie WB, Tuttle TM. Are mastectomy rates really increasing in the United States? J Clin Oncol 2010;28:3437-41.
15. Albornoz C, Cemal Y, Mehrara B, Disa J, Pusic AL, McCarthy C, et al. The impact of bilateral mastectomy on reconstructive rate and method in the United States: a population based analysis. Plast Reconstr Surg 2012;130(SS-1):3441.
16. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2004;11:CD002748.
17. Carlson GW. Technical advances in skin sparing mastectomy. Int J Surg Oncol 2011;2011:396901.
18. Romics L Jr, Chew BK, Weiler-Mithoff E, Doughty JC, Brown IM, Stallard S, et al. Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg 2012;99:799-806.
19. Nahabedian MY, Tsangaris TN. Breast reconstruction following subcutaneous mastectomy for cancer: a critical appraisal of the nipple-areola complex. Plast Reconstr Surg 2006;117:1083-90. (Pubitemid 44317792)
20. Didier F, Radice D, Gandini S, Bedolis R, Rotmensz N, Maldifassi A, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat 2009;118:623-33.
21. Rusby JE, Smith BL, Gui GP. Nipple-sparing mastectomy. Br J Surg 2010;97:305-16.
22. Loewen MJ, Jennings JA, Sherman SR, Slaikeu J, Ebrom PA, Davis AT, et al. Mammographic distance as a predictor of nipple-areola complex involvement in breast cancer. Am J Surg 2008;195:391-4; discussion 94-5.
23. Lambert PA, Kolm P, Perry RR. Parameters that predict nipple involvement in breast cancer. J Am Coll Surg 2000;191:354-9.
24. Gould DJ, Hunt KK, Liu J, Kuerer HM, Crosby MA, Babiera G, et al. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg 2013;132:330e-8e.
25. Jensen JA, Lin JH, Kapoor N, Giuliano AE. Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy. Ann Surg Oncol 2012;19:3171-6.
26. National Mastectomy and Breast Reconstruction Audit Report 2011, 2011. www.rcseng.ac.uk/surgeons/research/surgical-research/docs/national-mastectomy- and-breastreconstructionaudit-fourth-report-2011.
27. Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study. Plast Reconstr Surg 2002;109:2265-74. (Pubitemid 34556202)
28. Sullivan SR, Fletcher DR, Isom CD, Isik FF. True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg 2008;122:19-28.
29. D'Souza N, Darmanin G, Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane Database Syst Rev 2011;7:CD008674.
30. Albornoz CR, Bach PB, Pusic AL, McCarthy CM, Mehrara BJ, Disa JJ, et al. The influence of sociodemographic factors and hospital characteristics on the method of breast reconstruction, including microsurgery: a US population-based study. Plast Reconstr Surg 2012;129:1071-9.
31. Salzberg CA, Dunavant C, Nocera N. Immediate breast reconstruction using porcine acellular dermal matrix (Strattice): long-term outcomes and complications. J Plast Reconstr Aesthet Surg 2013;66:323-8.
32. Salzberg CA, Ashikari AY, Koch RM, Chabner-Thompson E. An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm). Plast Reconstr Surg 2011;127:514-24.
33. Schmitz M, Bertram M, Kneser U, Keller AK, Horch RE. Experimental total wrapping of breast implants with acellular dermal matrix: A preventive tool against capsular contracture in breast surgery? J Plast Reconstr Aesthet Surg 2013;33:675-80.
34. Sbitany H, Serletti JM. Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity. Plast Reconstr Surg 2011;128:1162-9.
35. Health Do. Progress report after one year on the MHRA and DH response to the recommendations of the Howe review into Poly Implant Protheìse (PIP) breast implants. 2013. www.mhra.gov. uk/home/groups/comms-po/documents/news/ con286825.pdf.
36. Yueh JH, Slavin SA, Adesiyun T, Nyame TT, Gautam S, Morris DJ, et al. Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg 2010;125:1585-95.
37. Fischer JP, Nelson JA, Cleveland E, Sieber B, Rohrbach JI, Serletti JM, et al. Breast reconstruction modality outcome study: a comparison of expander/implants and free flaps in select patients. Plast Reconstr Surg 2013;131:928-34.
38. Hu ES, Pusic AL, Waljee JF, Kuhn L, Hawley ST, Wilkins E, et al. Patient-reported aesthetic satisfaction with breast reconstruction during the long-term survivorship period. Plast Reconstr Surg 2009;124:1-8.
39. Spear SL, Newman MK, Bedford MS, Schwartz KA, Cohen M, Schwartz JS. A retrospective analysis of outcomes using three common methods for immediate breast reconstruction. Plast Reconstr Surg 2008;122:340-7.
40. Spear SL, Ducic I, Cuoco F, Taylor N. Effect of obesity on flap and donor-site complications in pedicled TRAM flap breast reconstruction. Plast Reconstr Surg 2007;119:788-95.
41. Clough KB, Louis-Sylvestre C, Fitoussi A, Couturaud B, Nos C. Donor site sequelae after autologous breast reconstruction with an extended latissimus dorsi flap. Plast Reconstr Surg 2002;109:1904-11. (Pubitemid 34492417)
42. Gagnon AR, Blondeel N. Superior gluteal artery perforator flap. Semin Plast Surg 2006;20:79-88
43. Blondeel PN, Van Landuyt K, Hamdi M, Monstrey SJ. Soft tissue reconstruction with the superior gluteal artery perforator flap. Clin Plast Surg 2003;30:371-82. (Pubitemid 36859398)
44. LoTempio MM, Allen RJ. Breast reconstruction with SGAP and IGAP flaps. Plast Reconstr Surg 2010;126:393-401.
45. Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, et al. Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2012;216:229-38.
46. Garvey PB, Buchel EW, Pockaj BA, Casey WJ, 3rd, Gray RJ, Hernandez JL, et al. DIEP and pedicled TRAM flaps: a comparison of outcomes. Plast Reconstr Surg 2006;117:1711-9; discussion 20-1. (Pubitemid 44324350)
47. Nahabedian MY, Momen B, Galdino G, Manson PN. Breast reconstruction with the free TRAM or DIEP flap: patient selection, choice of flap, and outcome. Plast Reconstr Surg 2002;110:466-75; discussion 76-7. (Pubitemid 34815947)
48. Chen CM, Halvorson EG, Disa JJ, McCarthy C, Hu QY, Pusic AL, et al. Immediate postoperative complications in DIEP versus free/muscle-sparing TRAM flaps. Plast Reconstr Surg 2007;120:1477-82. (Pubitemid 351339120)
49. Buck DW, 2nd, Shenaq D, Heyer K, Kato C, Kim JY. Patient-subjective cosmetic outcomes following the varying stages of tissue expander breast reconstruction: the importance of completion. Breast 2010;19:521-6.
50. Momoh AO, Colakoglu S, de Blacam C, Yueh JH, Lin SJ, Tobias AM, et al. The impact of nipple reconstruction on patient satisfaction in breast reconstruction. Ann Plast Surg 2012;69:389-93.
51. Goh SC, Martin NA, Pandya AN, Cutress RI. Patient satisfaction following nipple-areolar complex reconstruction and tattooing. J Plast Reconstr Aesthet Surg 2011;64:360-3.
52. Petit JY, Lohsiriwat V, Clough KB, Sarfati I, Ihrai T, Rietjens M, et al. The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study-Milan-Paris-Lyon experience of 646lipofilling procedures. Plast Reconstr Surg 2011;128:341-6.
53. Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25years of experience. Aesthetic Plast Surg 2009;33:706-15.
54. Prabhu R, Godette K, Carlson G, Losken A, Gabram S, Fasola C, et al. The impact of skin-sparing mastectomy with immediate reconstruction in patients with stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation. Int J Radiat Oncol Biol Phys 2012;82:e587-93.
55. Tallet AV, Salem N, Moutardier V, Ananian P, Braud AC, Zalta R, et al. Radiotherapy and immediate two-stage breast reconstruction with a tissue expander and implant: complications and esthetic results. Int J Radiat Oncol Biol Phys 2003;57:136-42. (Pubitemid 36959749)
56. Cowen D, Gross E, Rouannet P, Teissier E, Ellis S, Resbeut M, et al. Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications. Breast Cancer Res Treat 2010;121:627-34.
57. Christensen BO, Overgaard J, Kettner LO, Damsgaard TE. Long-term evaluation of postmastectomy breast reconstruction. Acta Oncol 2011;50:1053-61.
58. Behranwala KA, Dua RS, Ross GM, Ward A, A'Hern R, Gui GP. The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 2006;59:1043-51. (Pubitemid 44391162)
59. Bentzen SM, Overgaard M, Thames HD, Christensen JJ, Overgaard J. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989;56:711-5. (Pubitemid 20002018)
60. Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 1994;30:1073-81. (Pubitemid 24362516)
61. Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H, et al. Predictors of the risk of fibrosis at 10years after breast conserving therapy for early breast cancer: a study based on the EORTC trial 22881-10882 "boost versus no boost." Eur J Cancer 2008;44:2587-99.
62. Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 2009;124:395-408.
63. Spear SL, Ducic I, Low M, Cuoco F. The effect of radiation on pedicled TRAM flap breast reconstruction: outcomes and implications. Plast Reconstr Surg 2005;115:84-95. (Pubitemid 40187801)
64. Thomson HJ, Potter S, Greenwood RJ, Bahl A, Barker J, Cawthorn SJ, et al. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the influence of radiotherapy. Ann Surg Oncol 2008;15:1081-91.
65. Monrigal E, Dauplat J, Gimbergues P, Le Bouedec G, Peyronie M, Achard JL, et al. Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20years single institution study. Eur J Surg Oncol 2011;37:864-70.
66. Warren Peled A, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, et al. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 2010;145:880-5.
67. Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, et al. Impact of neoadjuvant chemotherapy on breast reconstruction. Cancer 2011;117:2833-41.
68. Wilson CR, Brown IM, Weiller-Mithoff E, George WD, Doughty JC. Immediate breast reconstruction does not lead to a delay in the delivery of adjuvant chemotherapy. Eur J Surg Oncol 2004;30:624-7. (Pubitemid 39060731)
69. Hamahata A, Kubo K, Takei H, Saitou T, Hayashi Y, Matsumoto H, et al. Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study. Breast Cancer 2013; published online 12Jun.
70. Taylor CW, Kumar S. The effect of immediate breast reconstruction on adjuvant chemotherapy. Breast 2005;14:18-21. (Pubitemid 40197822)
71. Allweis TM, Boisvert ME, Otero SE, Perry DJ, Dubin NH, Priebat DA. Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy. Am J Surg 2002;183:218-21. (Pubitemid 34273973)
72. Lee J, Lee SK, Kim S, Koo MY, Choi MY, Bae SY, et al. Does immediate breast reconstruction after mastectomy affect the initiation of adjuvant chemotherapy? J Breast Cancer 2011;14:322-7.
73. Alderman AK, Collins ED, Schott A, Hughes ME, Ottesen RA, Theriault RL, et al. The impact of breast reconstruction on the delivery of chemotherapy. Cancer 2010;116:1791-800
74. Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 2006;24:4888-94. (Pubitemid 46630916)
75. Cold S, During M, Ewertz M, Knoop A, Moller S. Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer 2005;93:627-32. (Pubitemid 41486452)
76. Pusic AL, Klassen AF, Snell L, Cano SJ, McCarthy C, Scott A, et al. Measuring and managing patient expectations for breast reconstruction: impact on quality of life and patient satisfaction. Expert Rev Pharmacoecon Outcomes Res 2012;12:149-58.